TY  - GEN
AU  - Mileshkin,Linda
AU  - Edmondson,Richard
AU  - O'Connell,Rachel L
AU  - Sjoquist,Katrin M
AU  - Andrews,John
AU  - Jyothirmayi,Rema
AU  - Beale,Philip
AU  - Bonaventura,Tony
AU  - Goh,Jeffrey
AU  - Hall,Marcia
AU  - Clamp,Andrew
AU  - Green,John
AU  - Lord,Rosemary
AU  - Amant,Frédéric
AU  - Alexander,Laura
AU  - Carty,Karen
AU  - Paul,James
AU  - Scurry,James
AU  - Millan,David
AU  - Nottley,Steven
AU  - Friedlander,Michael
TI  - Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903
SN  - 1095-6859
PY  - 2019///0826
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Anastrozole
KW  - therapeutic use
KW  - Endometrial Neoplasms
KW  - drug therapy
KW  - Female
KW  - Humans
KW  - Immunohistochemistry
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Progression-Free Survival
KW  - Quality of Life
KW  - Receptors, Estrogen
KW  - metabolism
KW  - Receptors, Progesterone
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ygyno.2019.05.007
ER  -